Join
Live feed
·
PRReleasevia Quantisnow
bioAffinity Technologies Inc. logo

Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies' Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar

ByQuantisnow·Wall Street's wire, on your screen.
BIAF· bioAffinity Technologies Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track BIAF (bioAffinity Technologies Inc.) and more on Quantisnow.